360Dx Index Up 7 Percent in June, Rebounding From May Downturn
Of the 30 companies in the index, 24 firms saw their stock prices increase, while six firms' share prices decreased.
NantHealth Q1 Revenues Decline 11 Percent
NantHealth reported a net loss of $15.4 million during the quarter, as sequencing and molecular analysis revenues fell to just $3,000.
Bucking Downward 2021 Trend, 360Dx Index Rebounds 4 Percent in April
Of the 30 companies in the index, 18 firms saw their stock prices increase, while 12 saw their share prices decline.
NantHealth Lands $137.5M in Financing to Extend Debt Maturity Date
The firm won't have to pay off its unsecured convertible notes until 2026 to investors, including Patrick Soon-Shiong's Nant Capital.
NantHealth Q4 Revenues Flat From Year Ago
The firm posted total software-related revenues of $18.6 million, up 1 percent from $18.4 million in Q4 2019.
Nov 5, 2020
NantHealth Q3 Revenues Tick Up Slightly
Aug 6, 2020
NantHealth Q2 Revenues Decline 12 Percent
May 7, 2020
NantHealth Q1 Revenues Decline 10 Percent
Feb 29, 2020
NantHealth Q4 Revenues Grow 6 Percent
Nov 19, 2019
Nov 12, 2019
FDA Clears NantHealth Tumor-Normal Whole-Exome Test
Nov 7, 2019